INBX
Inhibrx Biosciences
$82.45
+$0.90 (+1.1%)Jul 27, 2026
Key metrics
The numbers that frame INBX today
- Market cap
- $1.21B
- P/E (TTM)
- -9.3
- EV / FCF
- -9.3
- Gross margin
- 100%
- EV / Sales
- 945.3
- ROIC
- -101.7%
- Div yield
- 0%
- 52wk Low
- $20.55
- 52wk High
- $155.29
Growth
Revenue and earnings trend for INBX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about INBX
Is Inhibrx Biosciences a good buy?
Yes. Inhibrx Biosciences has excellent momentum, and it outweighs the poor quality here. Growth looks strong, which supports the long-term business case. We think Inhibrx Biosciences is selling at a very high price, which cuts against the buy case.
What is the market capitalization of INBX?
Inhibrx Biosciences's market capitalization is $1.21B.
What is the P/E ratio for INBX stock?
Inhibrx Biosciences's current P/E ratio is -9.3.
What is the 52-week high for INBX stock?
The 52-week high for Inhibrx Biosciences is $155.29. The current close of $82.45 is 46.9% below that high.
What is the 52-week low for INBX stock?
The 52-week low for Inhibrx Biosciences is $20.55. The current close of $82.45 is 301.2% above that low.
Does INBX stock pay dividends?
Inhibrx Biosciences does not currently show a dividend per share in the company data.